| Proteintech Expands CGT Reagents Portfolio |
| Proteintech continues to expand its cell and gene therapy portfolio, with a strong focus on GMP-grade antibodies and CAR detection reagents, complementing one of the largest GMP-grade cytokine and growth factor portfolios available. Proteintech's CAR detection reagents enable an accurate assessment of CAR expression and functionality, from early discovery through lot-release quality testing of manufactured CGT products. Their GMP antibodies are engineered for consistency, traceability, and phase-appropriate use in key CGT workflows, including cell isolation and activation. Together, these solutions help minimize risk as programs progress toward the clinic. Partner with Proteintech for reliable reagents purpose-built for CGT success. |
| GMP-Grade Antibodies |
| CAR-Detection reagents |
